Navigation Links
Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
Date:11/17/2011

ALISO VIEJO, Calif., Nov. 17, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) announced today that the European Medicines Agency (EMA) has accepted the filing of the Marketing Authorization Application (MAA) for NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) for the treatment of pseudobulbar affect (PBA). Acceptance of the MAA confirms that the submission is sufficiently complete to permit a substantive review.

NUEDEXTA was approved by the U.S. Food and Drug Administration in October 2010 for the treatment of PBA, a neurologic condition which is characterized by frequent outbursts of involuntary crying or laughing.

The MAA is based on comprehensive clinical data from Avanir's controlled phase 3 studies of NUEDEXTA in patients with PBA, plus data from the company's longer-term safety studies. The MAA acceptance triggers the initiation of EMA's scientific assessment and opinion review period.

Additionally the company received notification from the EMA that the Name Review Group and the Committee for Medicinal Products for Human Use had no objections to the proposed use of the trade name NUEDEXTA.

About PBA

Patients suffering from existing neurological disease or brain injury may also suffer the added burden of pseudobulbar affect, or PBA. PBA occurs secondary to a variety of otherwise unrelated neurological conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the patient's underlying emotional state. PBA outbursts result from a "short circuit" in the brain caused by another neurologic condition--such as multiple sclerosis, amyotrophic lateral sclerosis (or Lou Gehrig's disease), stroke, traumatic brain injury, Parkinson's disease or dementias including Alzheimer's. PBA can have a debilitating impa
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Avanir Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA
2. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
3. Avanir Pharmaceuticals to Participate in Two Investor Conferences
4. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
5. Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
6. Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
7. Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
8. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
9. Avanir Pharmaceuticals Provides Update on European Regulatory Filing for NUEDEXTA
10. Avanir Pharmaceuticals Announces Paragraph IV ANDA Filing for NUEDEXTA
11. Avanir Pharmaceuticals Reports Fiscal 2011 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... LA HABRA, Calif. , May 1, 2015 /PRNewswire-USNewswire/ ... to announce its 2015 health literacy award winners. The ... reward initiatives that make an impact on the practice ... that advance health literacy. IHA gives awards in three ... IHA also bestowed its Health Literacy Hero award. ...
(Date:5/1/2015)... 1, 2015 Semler Scientific, Inc. (Nasdaq: ... develops, manufactures and markets products that assist healthcare providers ... financial results for the first quarter ended March 31, ... 2015, Semler reported continued progress with year over year ... growth of 14%," said Doug Murphy-Chutorian , M.D., ...
(Date:5/1/2015)... NEW YORK , May 1, 2015  Shares ... over 70% of their value yesterday following the results ... company,s glaucoma therapy, Rhopressa.  Despite the trial failing to ... indicates that positive results may come from future studies. ... a brief company overview, current pipeline, financial review, analyst ...
Breaking Medicine Technology:Institute for Healthcare Advancement Announces 2015 Award Winners 2Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
(Date:5/3/2015)... 03, 2015 Looking for a ... directly impact your career? The Master of International ... leaders in multinational companies and for professionals seeking ... changing global landscape, differences in culture, religion, government, ... EMIB program develops the global competence and confidence ...
(Date:5/3/2015)... 2015 SpineFrontier, a Less Exposure Surgery ... to produce and market their new sacroiliac joint fusion ... in outpatient settings and is compatible with both lateral ... has been extensively researched and refined by SpineFrontier, the ... this approach in conjunction with a sacroiliac joint fusion ...
(Date:5/3/2015)... 2015 HealthPostures, a pioneering ergonomics ... its appearance at the , May 5 - 7, ... will exhibit at the conference include its bestselling TaskMate ... solutions is the 6100 TaskMate Executive. Features of the ... adjustable keyboard tray, extended platform work surface and supply ...
(Date:5/2/2015)... NV (PRWEB) May 02, 2015 Ticket Down ... tickets for the long awaited event today, Saturday, May ... Diehard boxing fans will be able to secure tickets ... , The fight that boxing fans have wanted for more ... months ago. Floyd “Money” Mayweather will step inside the ring ...
(Date:5/2/2015)... ActOn ” was featured on NewsWatch as part of its ... coolest applications on the market for iOS, Android, and Windows. ... the app review and shared with viewers how this app ... difference. , In this material world, almost everything is about ... which is why those things should be prioritized above others. ...
Breaking Medicine News(10 mins):Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2
... who were treated with anti-tumor necrosis factor alpha, ... exacerbations than individuals taking a placebo. ,This ... 2006 of the American Journal of Respiratory and ... Society. ,Trevor T. Hansel, M.D., Ph.D., ...
... care in United Kingdom, and a munificent grant of ?45 ... figure anywhere on the NHS dental list. , ,The ... NHS registrations, down by a 42000 enrollments. This, notwithstanding the ... to ensure registrations are maintained. Yet, it has not made ...
... professor says that laws, which require minors to seek ... sexual behavior// in this segment of the society. Jonathan ... Thomas Stratmann, professor of economics at George Mason University ... laws seeking parental consent may play an important role. ...
... developed a prototype bandage that could detect hidden fractures once ... by Ozan Akkus and colleagues at Purdue University in Indiana ... created by tiny cracks in damaged bones, reported the online ... alarm, warning the patient to rest so that the injured ...
... capital has recorded 327 cases of dengue fever this year so ... ,According to health authorities here, two more people have died ... nine. ,Out of the 327 cases reported, 127 cases ... that the next two months is likely to see a surge ...
... The directory of patented drugs will play host to a ... to the recent communique // by the Director of patent ... in the arm for the multitude of generic drug manufacturers, ... the drug to developing nations. ,Biolyse ...
Cached Medicine News:Health News:Monoclonal Antibody Reduces Exacerbations in Asthmatics 2Health News:Laws That Make Parental Consent Mandatory Reduce Risky Sexual Behavior 2
... test system is intended for ... of VZ IgG antibody in ... fluorescent antibody (IFA) technique. The ... a recent infection or immune ...
... The Masimo SET LNOP Blue Sensor is ... babies. The LNOP Blue sensor is ... accuracy claims for cyanotic infants and children. ... presented challenging conditions for reliable and accurate ...
Inquire...
... Captia™ Varicella-Zoster Virus (VZV) IgG Enzyme-linked Immunosorbent ... and quantitative determination of IgG antibody to ... may be used for the determination of ... may be used to demonstrate seroconversion or ...
Medicine Products: